Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740596 · ClinicalTrials.gov registry record · NA

C-Pulse® System: A Heart Assist Device Clinical Study

A NA study, sponsored by Nuwellis.

Terminated
Registry status
NA
Development phase
38
Enrollment target

NCT01740596 is a NA study that was terminated before completion, run by Nuwellis. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740596, a NA study, was terminated before completion, sponsored by Nuwellis.

TERMINATED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Sunshine Heart is sponsoring a prospective, multi-center, randomized trial to assess the safety and efficacy of the C-Pulse® System ("C-Pulse"). The purpose of the study is to determine whether the use of the C-Pulse as a treatment for patients in moderate to severe heart failure (HF) has demonstrated safety and efficacy, such that the C-Pulse System merits Food and Drug Administration (FDA) approval to market the device in the United States.

Interventions

  • DEVICE C-Pulse® System Counterpulsation

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2012-09-12
Est. Completion 2018-10-26
Phase NA

Sponsor

Nuwellis

7 total trials

What the Registry Record Tells You About NCT01740596

The ClinicalTrials.gov registry entry for NCT01740596 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nuwellis, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which C-Pulse® System Counterpulsation is the first listed.

NCT01740596 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01740596 about?

NCT01740596 is a clinical study titled "C-Pulse® System: A Heart Assist Device Clinical Study". Sunshine Heart is sponsoring a prospective, multi-center, randomized trial to assess the safety and efficacy of the C-Pulse® System ("C-Pulse"). The purpose of the study is to determine whether the use of the C-Pulse as a treatment for patients in moderate to severe heart failure (HF) has demonstra...

What is the current status of trial NCT01740596?

This trial is currently terminated. It is a NA study. The enrollment target is 38 participants. The study started on 2012-09-12. Estimated completion is 2018-10-26.

What interventions are being tested in trial NCT01740596?

The interventions under investigation include: C-Pulse® System Counterpulsation (DEVICE).

Who is sponsoring clinical trial NCT01740596?

This trial is sponsored by Nuwellis, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.